Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Hepatoprotective effect of caffeine against ischemia-reperfusion damage
D Garza-Guzmán; L Torres-González; GR Govea-Torres; JM De la Rosa-García; CA Jiménez-Torres; DP Moreno-Peña; DR Rodríguez-Rodríguez; LE Muñoz-Espinosa; E Pérez-Rodríguez; P Cordero-Pérez;
Ann Hepatol. 2022;27 Supl 3:
Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C
M Lemus-Peña; D Montes de Oca-Ángeles; M Hernandez-Santillan; A Hernandez-Barragan; D Santana-Vargas; M Martinez-Castillo; Z Medina-Avila; A Torre-Delgadillo; JL Pérez-Hernández; F Higuera-De la Tijera; P Cordero-Pérez; L Muñoz-Espinosa; D Kershenobich; G Gutiérrez-Reyes;
Ann Hepatol. 2022;27 Supl 3:
Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption
M Hernandez-Santillan; M Martínez-Castillo; Z Medina-Ávila; M Lemus-Peña; D Montes de Oca-Ángeles; A Hernández-Barragan; JL Pérez-Hernández; F Higuera-De la Tijera; D Santana-Vargas; P Cordero-Pérez; L Muñoz-Espinoza; J Córdova-Gallardo; D Kershenobich; G Gutiérrez-Reyes;
Ann Hepatol. 2022;27 Supl 3: